FIELD: pharmaceutics.
SUBSTANCE: group of inventions relates to pharmaceutical industry, namely to pharmaceutical composition for the treatment of acute and chronic pain syndrome in the form of rectal suppositories, containing in 100 g of the composition: 0.40–8.00 g nefopam hydrochloride, 9.0–16.0 g polyethylene oxide 400 and hydrophilic emulsion base (up to 100 g); as well as to a process for preparing said composition, according to which nefopam hydrochloride is suspended in polyethylene oxide 400, then the resulting suspension is mixed with a cooled to 40-45 °C a molten hydrophilic emulsion base and homogenized, further, the suppository mass in the liquid state is dosed into the contourcell packagings and cooled to solidification.
EFFECT: group of inventions ensures provision of storage-stable suppositories of analgesic action comparable in effectiveness and duration with such an effect when administered intramuscularly.
11 cl, 4 ex, 8 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITIONS AS RECTAL SUPPOSITORIES CONTAINING NEFOPAM HYDROCHLORIDE (VERSIONS), THEIR APPLICATION FOR TREATMENT OF ACUTE AND CHRONIC PAIN SYNDROME AND METHODS FOR PRODUCTION | 2015 |
|
RU2646495C2 |
PHARMACEUTICAL COMPOSITION CONTAINING NALBUPHINE HYDROCHLORIDE, USING IT FOR TREATING MODERATE TO SEVERE PAIN SYNDROME | 2012 |
|
RU2513514C1 |
NEPHOPAM SUPPOSITORIES FOR THE TREATMENT OF ACUTE AND CHRONIC PAIN SYNDROME ON A LIPOPHILIC BASIS AND THE METHOD FOR THEIR PREPARATION | 2017 |
|
RU2661618C1 |
SUPPOSITORIES FOR TREATMENT OF MODERATE AND HIGH-INTENSITY PAIN SYNDROME | 2019 |
|
RU2723958C1 |
SUPPOSITORIES FOR TREATMENT OF MODERATE AND HIGH-INTENSITY PAIN SYNDROME | 2019 |
|
RU2723954C1 |
SUPPOSITORIES FOR TREATMENT OF MODERATE AND HIGH-INTENSITY PAIN SYNDROME | 2019 |
|
RU2723952C1 |
SUPPOSITORIES FOR TREATMENT OF MODERATE AND HIGH-INTENSITY PAIN SYNDROME | 2019 |
|
RU2723960C1 |
METHOD OF TREATING CHRONIC PAIN SYNDROME | 2014 |
|
RU2545915C1 |
TRANSDERMAL PREPARATION FOR TREATMENT AND PREVENTION OF DISEASES OF JOINTS AND SOFT TISSUES | 2018 |
|
RU2685436C1 |
TOPICAL AND EXTERNAL TILORONE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PURULENT-DESTRUCTIVE MUCOSAL AND SKIN DISEASES, SYSTEMIC DISEASES IN IMMUNODEFICIENCY STATES | 2008 |
|
RU2401104C2 |
Authors
Dates
2018-07-17—Published
2017-11-23—Filed